BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Suomalainen A, Isohanni P. Mitochondrial DNA depletion syndromes--many genes, common mechanisms. Neuromuscul Disord 2010;20:429-37. [PMID: 20444604 DOI: 10.1016/j.nmd.2010.03.017] [Cited by in Crossref: 144] [Cited by in F6Publishing: 127] [Article Influence: 12.0] [Reference Citation Analysis]
Number Citing Articles
1 Kao L, Ovchinnikov D, Wolvetang E. The effect of ethidium bromide and chloramphenicol on mitochondrial biogenesis in primary human fibroblasts. Toxicology and Applied Pharmacology 2012;261:42-9. [DOI: 10.1016/j.taap.2012.03.009] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
2 El-Hattab AW, Craigen WJ, Scaglia F. Mitochondrial DNA maintenance defects. Biochim Biophys Acta Mol Basis Dis 2017;1863:1539-55. [PMID: 28215579 DOI: 10.1016/j.bbadis.2017.02.017] [Cited by in Crossref: 107] [Cited by in F6Publishing: 99] [Article Influence: 21.4] [Reference Citation Analysis]
3 Ylikallio E, Tyynismaa H. Generating Mouse Models of Mitochondrial Disease. Movement Disorders. Elsevier; 2015. pp. 689-701. [DOI: 10.1016/b978-0-12-405195-9.00043-3] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
4 Matilainen S, Isohanni P, Euro L, Lönnqvist T, Pihko H, Kivelä T, Knuutila S, Suomalainen A. Mitochondrial encephalomyopathy and retinoblastoma explained by compound heterozygosity of SUCLA2 point mutation and 13q14 deletion. Eur J Hum Genet 2015;23:325-30. [PMID: 24986829 DOI: 10.1038/ejhg.2014.128] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.1] [Reference Citation Analysis]
5 Pohjoismäki JLO, Forslund JME, Goffart S, Torregrosa-muñumer R, Wanrooij S. Known Unknowns of Mammalian Mitochondrial DNA Maintenance. BioEssays 2018;40:1800102. [DOI: 10.1002/bies.201800102] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
6 Bottani E, Giordano C, Civiletto G, Di Meo I, Auricchio A, Ciusani E, Marchet S, Lamperti C, d'Amati G, Viscomi C, Zeviani M. AAV-mediated liver-specific MPV17 expression restores mtDNA levels and prevents diet-induced liver failure. Mol Ther 2014;22:10-7. [PMID: 24247928 DOI: 10.1038/mt.2013.230] [Cited by in Crossref: 28] [Cited by in F6Publishing: 24] [Article Influence: 3.1] [Reference Citation Analysis]
7 Roos S, Lindgren U, Ehrstedt C, Moslemi A, Oldfors A. Mitochondrial DNA depletion in single fibers in a patient with novel TK2 mutations. Neuromuscular Disorders 2014;24:713-20. [DOI: 10.1016/j.nmd.2014.05.009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.1] [Reference Citation Analysis]
8 Giovarelli M, Zecchini S, Catarinella G, Moscheni C, Sartori P, Barbieri C, Roux-Biejat P, Napoli A, Vantaggiato C, Cervia D, Perrotta C, Clementi E, Latella L, De Palma C. Givinostat as metabolic enhancer reverting mitochondrial biogenesis deficit in Duchenne Muscular Dystrophy. Pharmacol Res 2021;170:105751. [PMID: 34197911 DOI: 10.1016/j.phrs.2021.105751] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zabalza R, Nurminen A, Kaguni LS, Garesse R, Gallardo ME, Bornstein B. Co-occurrence of four nucleotide changes associated with an adult mitochondrial ataxia phenotype. BMC Res Notes 2014;7:883. [PMID: 25488682 DOI: 10.1186/1756-0500-7-883] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
10 Dimauro S, Emmanuele V. The Clinical Spectrum of Nuclear DNA-Related Mitochondrial Disorders. In: Wong LC, editor. Mitochondrial Disorders Caused by Nuclear Genes. New York: Springer; 2013. pp. 3-25. [DOI: 10.1007/978-1-4614-3722-2_1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
11 Bonnen PE, Yarham JW, Besse A, Wu P, Faqeih EA, Al-Asmari AM, Saleh MA, Eyaid W, Hadeel A, He L, Smith F, Yau S, Simcox EM, Miwa S, Donti T, Abu-Amero KK, Wong LJ, Craigen WJ, Graham BH, Scott KL, McFarland R, Taylor RW. Mutations in FBXL4 cause mitochondrial encephalopathy and a disorder of mitochondrial DNA maintenance. Am J Hum Genet 2013;93:471-81. [PMID: 23993193 DOI: 10.1016/j.ajhg.2013.07.017] [Cited by in Crossref: 88] [Cited by in F6Publishing: 84] [Article Influence: 9.8] [Reference Citation Analysis]
12 Jacinto S, Guerreiro P, de Oliveira RM, Cunha-Oliveira T, Santos MJ, Grazina M, Rego AC, Outeiro TF. MPV17 Mutations Are Associated With a Quiescent Energetic Metabolic Profile. Front Cell Neurosci 2021;15:641264. [PMID: 33815063 DOI: 10.3389/fncel.2021.641264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Sabouny R, Wong R, Lee-Glover L, Greenway SC, Sinasac DS, Khan A, Shutt TE; Care4Rare Canada. Characterization of the C584R variant in the mtDNA depletion syndrome gene FBXL4, reveals a novel role for FBXL4 as a regulator of mitochondrial fusion. Biochim Biophys Acta Mol Basis Dis 2019;1865:165536. [PMID: 31442532 DOI: 10.1016/j.bbadis.2019.165536] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
14 DiMauro S. Mitochondrial encephalomyopathies--fifty years on: the Robert Wartenberg Lecture. Neurology 2013;81:281-91. [PMID: 23858410 DOI: 10.1212/WNL.0b013e31829bfe89] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
15 Saito K, Kimura N, Oda N, Shimomura H, Kumada T, Miyajima T, Murayama K, Tanaka M, Fujii T. Pyruvate therapy for mitochondrial DNA depletion syndrome. Biochim Biophys Acta 2012;1820:632-6. [PMID: 21855607 DOI: 10.1016/j.bbagen.2011.08.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.6] [Reference Citation Analysis]
16 Nakhro K, Chung KW, Kim S, Sunwoo I, Cho EM, Park SW, Hwang JH, Choi B. Compound mutations of PEO1 and TYMP in a progressive external ophthalmoplegia patient with incomplete mitochondrial neurogastrointestinal encephalomyopathy phenotype. Genes Genom 2011;33:431-7. [DOI: 10.1007/s13258-011-0089-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
17 Chinopoulos C, Seyfried TN. Mitochondrial Substrate-Level Phosphorylation as Energy Source for Glioblastoma: Review and Hypothesis. ASN Neuro 2018;10:1759091418818261. [PMID: 30909720 DOI: 10.1177/1759091418818261] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 16.0] [Reference Citation Analysis]
18 Janssen W, Quaegebeur A, Van Goethem G, Ann L, Smets K, Vandenberghe R, Van Paesschen W. The spectrum of epilepsy caused by POLG mutations. Acta Neurol Belg 2016;116:17-25. [DOI: 10.1007/s13760-015-0499-8] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
19 Sun R, Wang L. Thymidine Kinase 2 Enzyme Kinetics Elucidate the Mechanism of Thymidine-Induced Mitochondrial DNA Depletion. Biochemistry 2014;53:6142-50. [DOI: 10.1021/bi5006877] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
20 Kasapkara ÇS, Tümer L, Küçükçongar A, Hasanoğlu A, Seneca S, De Meirleir L. DGUOK-Related Mitochondrial DNA Depletion Syndrome in a Child With an Early Diagnosis of Glycogen Storage Disease. Journal of Pediatric Gastroenterology & Nutrition 2013;57:e28-9. [DOI: 10.1097/mpg.0b013e31826bd4ed] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
21 Mozhey OI, Zatolokin PA, Vasilenko MA, Litvinova LS, Kirienkova EV, Mazunin IO. Evaluating the number of mitochondrial DNA copies in leukocytes and adipocytes from metabolic syndrome patients: Pilot study. Mol Biol 2014;48:590-3. [DOI: 10.1134/s0026893314040074] [Cited by in Crossref: 6] [Article Influence: 0.8] [Reference Citation Analysis]
22 DiMauro S, Schon EA, Carelli V, Hirano M. The clinical maze of mitochondrial neurology. Nat Rev Neurol 2013;9:429-44. [PMID: 23835535 DOI: 10.1038/nrneurol.2013.126] [Cited by in Crossref: 210] [Cited by in F6Publishing: 178] [Article Influence: 23.3] [Reference Citation Analysis]
23 Pyal A, Paramasivam A, Meena AK, Bhavana VB, Thangaraj K. MPV17 hepatocerebral mitochondrial DNA depletion syndrome presenting as acute flaccid paralysis - A case report. Mitochondrion 2017;37:41-5. [PMID: 28673863 DOI: 10.1016/j.mito.2017.06.006] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
24 Nogueira C, de Souza CF, Husny A, Derks TG, Santorelli FM, Vilarinho L. MPV17: fatal hepatocerebral presentation in a Brazilian infant. Mol Genet Metab 2012;107:764. [PMID: 23137571 DOI: 10.1016/j.ymgme.2012.10.010] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
25 Hurko O. Drug development for rare mitochondrial disorders. Neurotherapeutics 2013;10:286-306. [PMID: 23430661 DOI: 10.1007/s13311-013-0179-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
26 Bannwarth S, Ait-El-Mkadem S, Chaussenot A, Genin EC, Lacas-Gervais S, Fragaki K, Berg-Alonso L, Kageyama Y, Serre V, Moore DG, Verschueren A, Rouzier C, Le Ber I, Augé G, Cochaud C, Lespinasse F, N'Guyen K, de Septenville A, Brice A, Yu-Wai-Man P, Sesaki H, Pouget J, Paquis-Flucklinger V. A mitochondrial origin for frontotemporal dementia and amyotrophic lateral sclerosis through CHCHD10 involvement. Brain 2014;137:2329-45. [PMID: 24934289 DOI: 10.1093/brain/awu138] [Cited by in Crossref: 266] [Cited by in F6Publishing: 247] [Article Influence: 33.3] [Reference Citation Analysis]
27 Lindgren U, Roos S, Hedberg Oldfors C, Moslemi A, Lindberg C, Oldfors A. Mitochondrial pathology in inclusion body myositis. Neuromuscular Disorders 2015;25:281-8. [DOI: 10.1016/j.nmd.2014.12.010] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 2.4] [Reference Citation Analysis]
28 Wyatt LH, Luz AL, Cao X, Maurer LL, Blawas AM, Aballay A, Pan WK, Meyer JN. Effects of methyl and inorganic mercury exposure on genome homeostasis and mitochondrial function in Caenorhabditis elegans. DNA Repair (Amst) 2017;52:31-48. [PMID: 28242054 DOI: 10.1016/j.dnarep.2017.02.005] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 4.6] [Reference Citation Analysis]
29 Finsterer J, G Kovacs G, Ahting U. Adult mitochondrial DNA depletion syndrome with mild manifestations. Neurol Int. 2013;5:28-30. [PMID: 23888212 DOI: 10.4081/ni.2013.e9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
30 Tyynismaa H, Sun R, Ahola-Erkkilä S, Almusa H, Pöyhönen R, Korpela M, Honkaniemi J, Isohanni P, Paetau A, Wang L, Suomalainen A. Thymidine kinase 2 mutations in autosomal recessive progressive external ophthalmoplegia with multiple mitochondrial DNA deletions. Hum Mol Genet 2012;21:66-75. [PMID: 21937588 DOI: 10.1093/hmg/ddr438] [Cited by in Crossref: 61] [Cited by in F6Publishing: 55] [Article Influence: 5.5] [Reference Citation Analysis]
31 Maalej M, Tej A, Bouguila J, Tilouche S, Majdoub S, Khabou B, Tabbebi M, Felhi R, Ammar M, Mkaouar-Rebai E, Keskes L, Boughamoura L, Fakhfakh F. Clinical, Molecular, and Computational Analysis in two cases with mitochondrial encephalomyopathy associated with SUCLG1 mutation in a consanguineous family. Biochem Biophys Res Commun 2018;495:1730-7. [PMID: 29217198 DOI: 10.1016/j.bbrc.2017.12.011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
32 Mahjoub G, Habibzadeh P, Dastsooz H, Mirzaei M, Kavosi A, Jamali L, Javanmardi H, Katibeh P, Faghihi MA, Dastgheib SA. Clinical and molecular characterization of three patients with Hepatocerebral form of mitochondrial DNA depletion syndrome: a case series. BMC Med Genet 2019;20:167. [PMID: 31664948 DOI: 10.1186/s12881-019-0893-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
33 Thompson K, Majd H, Dallabona C, Reinson K, King MS, Alston CL, He L, Lodi T, Jones SA, Fattal-Valevski A, Fraenkel ND, Saada A, Haham A, Isohanni P, Vara R, Barbosa IA, Simpson MA, Deshpande C, Puusepp S, Bonnen PE, Rodenburg RJ, Suomalainen A, Õunap K, Elpeleg O, Ferrero I, McFarland R, Kunji ER, Taylor RW. Recurrent De Novo Dominant Mutations in SLC25A4 Cause Severe Early-Onset Mitochondrial Disease and Loss of Mitochondrial DNA Copy Number. Am J Hum Genet 2016;99:860-76. [PMID: 27693233 DOI: 10.1016/j.ajhg.2016.08.014] [Cited by in Crossref: 58] [Cited by in F6Publishing: 52] [Article Influence: 9.7] [Reference Citation Analysis]
34 Goldstein A, Bhatia P, Vento JM. Update on nuclear mitochondrial genes and neurologic disorders. Semin Pediatr Neurol 2012;19:181-93. [PMID: 23245551 DOI: 10.1016/j.spen.2012.09.005] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
35 Gorman GS, Chinnery PF, DiMauro S, Hirano M, Koga Y, McFarland R, Suomalainen A, Thorburn DR, Zeviani M, Turnbull DM. Mitochondrial diseases. Nat Rev Dis Primers 2016;2:16080. [PMID: 27775730 DOI: 10.1038/nrdp.2016.80] [Cited by in Crossref: 475] [Cited by in F6Publishing: 411] [Article Influence: 79.2] [Reference Citation Analysis]
36 Dong HL, Ma Y, Li QF, Du YC, Yang L, Chen S, Wu ZY. Genetic and clinical features of Chinese patients with mitochondrial ataxia identified by targeted next-generation sequencing. CNS Neurosci Ther 2019;25:21-9. [PMID: 29756269 DOI: 10.1111/cns.12972] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
37 Ramón J, Vila-Julià F, Molina-Granada D, Molina-Berenguer M, Melià MJ, García-Arumí E, Torres-Torronteras J, Cámara Y, Martí R. Therapy Prospects for Mitochondrial DNA Maintenance Disorders. Int J Mol Sci 2021;22:6447. [PMID: 34208592 DOI: 10.3390/ijms22126447] [Reference Citation Analysis]
38 Rooney JP, Luz AL, González-Hunt CP, Bodhicharla R, Ryde IT, Anbalagan C, Meyer JN. Effects of 5'-fluoro-2-deoxyuridine on mitochondrial biology in Caenorhabditis elegans. Exp Gerontol 2014;56:69-76. [PMID: 24704715 DOI: 10.1016/j.exger.2014.03.021] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 3.5] [Reference Citation Analysis]
39 Fukunaga H. Mitochondrial DNA Copy Number and Developmental Origins of Health and Disease (DOHaD). Int J Mol Sci 2021;22:6634. [PMID: 34205712 DOI: 10.3390/ijms22126634] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
40 Suomalainen A, Battersby BJ. Mitochondrial diseases: the contribution of organelle stress responses to pathology. Nat Rev Mol Cell Biol 2018;19:77-92. [DOI: 10.1038/nrm.2017.66] [Cited by in Crossref: 175] [Cited by in F6Publishing: 156] [Article Influence: 35.0] [Reference Citation Analysis]
41 Selim LA, Hassaan H. Mitochondrial Diseases as Model of Neurodegeneration. In: El-khamisy S, editor. Personalised Medicine. Cham: Springer International Publishing; 2017. pp. 129-55. [DOI: 10.1007/978-3-319-60733-7_8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
42 Scaglia F. Nuclear Gene Defects in Mitochondrial Disorders. In: Wong, Ph.d. LC, editor. Mitochondrial Disorders. Totowa: Humana Press; 2012. pp. 17-34. [DOI: 10.1007/978-1-61779-504-6_2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.7] [Reference Citation Analysis]
43 Bijarnia-Mahay S, Mohan N, Goyal D, Verma IC. Mitochondrial DNA depletion syndrome causing liver failure. Indian Pediatr 2014;51:666-8. [PMID: 25129007 DOI: 10.1007/s13312-014-0475-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
44 Wang YE, Marinov GK, Wold BJ, Chan DC. Genome-wide analysis reveals coating of the mitochondrial genome by TFAM. PLoS One 2013;8:e74513. [PMID: 23991223 DOI: 10.1371/journal.pone.0074513] [Cited by in Crossref: 32] [Cited by in F6Publishing: 32] [Article Influence: 3.6] [Reference Citation Analysis]
45 Gandhi VV, Samuels DC. A review comparing deoxyribonucleoside triphosphate (dNTP) concentrations in the mitochondrial and cytoplasmic compartments of normal and transformed cells. Nucleosides Nucleotides Nucleic Acids 2011;30:317-39. [PMID: 21774628 DOI: 10.1080/15257770.2011.586955] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
46 Chang C, Chiu L, Wei Y, Shieh D, Lee G. Integrated three-dimensional system-on-chip for direct quantitative detection of mitochondrial DNA mutation in affected cells. Biosensors and Bioelectronics 2013;48:6-11. [DOI: 10.1016/j.bios.2013.02.015] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
47 Montoya J, Arenas J, Ruiz-pesini E, Martín-casanueva MA. Las enfermedades raras en las patologías neurometabólicas. Arbor 2018;194:461. [DOI: 10.3989/arbor.2018.789n3003] [Reference Citation Analysis]
48 Chinopoulos C, Batzios S, van den Heuvel LP, Rodenburg R, Smeets R, Waterham HR, Turkenburg M, Ruiter JP, Wanders RJA, Doczi J, Horvath G, Dobolyi A, Vargiami E, Wevers RA, Zafeiriou D. Mutated SUCLG1 causes mislocalization of SUCLG2 protein, morphological alterations of mitochondria and an early-onset severe neurometabolic disorder. Mol Genet Metab 2019;126:43-52. [PMID: 30470562 DOI: 10.1016/j.ymgme.2018.11.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
49 Kacso G, Ravasz D, Doczi J, Németh B, Madgar O, Saada A, Ilin P, Miller C, Ostergaard E, Iordanov I, Adams D, Vargedo Z, Araki M, Araki K, Nakahara M, Ito H, Gál A, Molnár MJ, Nagy Z, Patocs A, Adam-Vizi V, Chinopoulos C. Two transgenic mouse models for β-subunit components of succinate-CoA ligase yielding pleiotropic metabolic alterations. Biochem J 2016;473:3463-85. [PMID: 27496549 DOI: 10.1042/BCJ20160594] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.5] [Reference Citation Analysis]
50 Luz AL, Meyer JN. Effects of reduced mitochondrial DNA content on secondary mitochondrial toxicant exposure in Caenorhabditis elegans. Mitochondrion 2016;30:255-64. [PMID: 27566481 DOI: 10.1016/j.mito.2016.08.014] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.7] [Reference Citation Analysis]
51 Tulinius M, Oldfors A. Neonatal muscular manifestations in mitochondrial disorders. Semin Fetal Neonatal Med 2011;16:229-35. [PMID: 21596636 DOI: 10.1016/j.siny.2011.04.001] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
52 Blakely EL, Butterworth A, Hadden RD, Bodi I, He L, McFarland R, Taylor RW. MPV17 mutation causes neuropathy and leukoencephalopathy with multiple mtDNA deletions in muscle. Neuromuscul Disord 2012;22:587-91. [PMID: 22508010 DOI: 10.1016/j.nmd.2012.03.006] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.3] [Reference Citation Analysis]
53 Arbustini E, Grasso M. Human "nuclear" mitochondrial cardiomyopathy a novel mouse model characterizes the disease. JACC Cardiovasc Imaging 2011;4:11-5. [PMID: 21232698 DOI: 10.1016/j.jcmg.2010.08.019] [Reference Citation Analysis]
54 Audano M, Pedretti S, Cermenati G, Brioschi E, Diaferia GR, Ghisletti S, Cuomo A, Bonaldi T, Salerno F, Mora M, Grigore L, Garlaschelli K, Baragetti A, Bonacina F, Catapano AL, Norata GD, Crestani M, Caruso D, Saez E, De Fabiani E, Mitro N. Zc3h10 is a novel mitochondrial regulator. EMBO Rep 2018;19:e45531. [PMID: 29507079 DOI: 10.15252/embr.201745531] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.8] [Reference Citation Analysis]
55 Burté F, Carelli V, Chinnery PF, Yu-wai-man P. Disturbed mitochondrial dynamics and neurodegenerative disorders. Nat Rev Neurol 2015;11:11-24. [DOI: 10.1038/nrneurol.2014.228] [Cited by in Crossref: 380] [Cited by in F6Publishing: 361] [Article Influence: 47.5] [Reference Citation Analysis]
56 Gilberti M, Baruffini E, Donnini C, Dallabona C. Pathological alleles of MPV17 modeled in the yeast Saccharomyces cerevisiae orthologous gene SYM1 reveal their inability to take part in a high molecular weight complex. PLoS One 2018;13:e0205014. [PMID: 30273399 DOI: 10.1371/journal.pone.0205014] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
57 Müller-Nedebock AC, Brennan RR, Venter M, Pienaar IS, van der Westhuizen FH, Elson JL, Ross OA, Bardien S. The unresolved role of mitochondrial DNA in Parkinson's disease: An overview of published studies, their limitations, and future prospects. Neurochem Int 2019;129:104495. [PMID: 31233840 DOI: 10.1016/j.neuint.2019.104495] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
58 Tkaczyk–wlizło A, Kowal K, Ślaska B. Mitochondrial DNA alterations in the domestic dog (Canis lupus familiaris) and their association with development of diseases: a review. Mitochondrion 2022. [DOI: 10.1016/j.mito.2022.02.001] [Reference Citation Analysis]
59 De Paepe B, Smet J, Vanlander A, Seneca S, Lissens W, De Meirleir L, Vandewoestyne M, Deforce D, Rodenburg RJ, Van Coster R. Fluorescence imaging of mitochondria in cultured skin fibroblasts: a useful method for the detection of oxidative phosphorylation defects. Pediatr Res 2012;72:232-40. [PMID: 22728747 DOI: 10.1038/pr.2012.84] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
60 Saada A. The use of individual patient's fibroblasts in the search for personalized treatment of nuclear encoded OXPHOS diseases. Mol Genet Metab 2011;104:39-47. [PMID: 21835663 DOI: 10.1016/j.ymgme.2011.07.016] [Cited by in Crossref: 20] [Cited by in F6Publishing: 17] [Article Influence: 1.8] [Reference Citation Analysis]
61 Landoni JC, Wang L, Suomalainen A. Whole-Cell and Mitochondrial dNTP Pool Quantification from Cells and Tissues. Methods Mol Biol 2021;2276:143-51. [PMID: 34060038 DOI: 10.1007/978-1-0716-1266-8_10] [Reference Citation Analysis]
62 Donti TR, Masand R, Scott DA, Craigen WJ, Graham BH. Expanding the phenotypic spectrum of Succinyl-CoA ligase deficiency through functional validation of a new SUCLG1 variant. Mol Genet Metab 2016;119:68-74. [PMID: 27484306 DOI: 10.1016/j.ymgme.2016.07.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.2] [Reference Citation Analysis]
63 Donti TR, Stromberger C, Ge M, Eldin KW, Craigen WJ, Graham BH. Screen for abnormal mitochondrial phenotypes in mouse embryonic stem cells identifies a model for succinyl-CoA ligase deficiency and mtDNA depletion. Dis Model Mech 2014;7:271-80. [PMID: 24271779 DOI: 10.1242/dmm.013466] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
64 Komulainen T, Hautakangas MR, Hinttala R, Pakanen S, Vähäsarja V, Lehenkari P, Olsen P, Vieira P, Saarenpää-Heikkilä O, Palmio J, Tuominen H, Kinnunen P, Majamaa K, Rantala H, Uusimaa J. Mitochondrial DNA Depletion and Deletions in Paediatric Patients with Neuromuscular Diseases: Novel Phenotypes. JIMD Rep 2015;23:91-100. [PMID: 25940035 DOI: 10.1007/8904_2015_438] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
65 Weiss ER, Osawa S, Xiong Y, Dhungana S, Carlson J, McRitchie S, Fennell TR. Broad spectrum metabolomics for detection of abnormal metabolic pathways in a mouse model for retinitis pigmentosa. Exp Eye Res 2019;184:135-45. [PMID: 30885711 DOI: 10.1016/j.exer.2019.03.007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
66 Nasehi M, Torabinejad S, Hashemi M, Vaseghi S, Zarrindast MR. Effect of cholestasis and NeuroAid treatment on the expression of Bax, Bcl-2, Pgc-1α and Tfam genes involved in apoptosis and mitochondrial biogenesis in the striatum of male rats. Metab Brain Dis 2020;35:183-92. [PMID: 31773435 DOI: 10.1007/s11011-019-00508-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
67 Tischner C, Wenz T. Keep the fire burning: Current avenues in the quest of treating mitochondrial disorders. Mitochondrion 2015;24:32-49. [DOI: 10.1016/j.mito.2015.06.002] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
68 Liu Y, Li X, Wang Q, Ding Y, Song J, Yang Y. Five novel SUCLG1 mutations in three Chinese patients with succinate-CoA ligase deficiency noticed by mild methylmalonic aciduria. Brain Dev 2016;38:61-7. [PMID: 26028457 DOI: 10.1016/j.braindev.2015.05.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
69 Miller C, Wang L, Ostergaard E, Dan P, Saada A. The interplay between SUCLA2, SUCLG2, and mitochondrial DNA depletion. Biochim Biophys Acta 2011;1812:625-9. [PMID: 21295139 DOI: 10.1016/j.bbadis.2011.01.013] [Cited by in Crossref: 36] [Cited by in F6Publishing: 36] [Article Influence: 3.3] [Reference Citation Analysis]
70 McKiernan P. Acute liver failure after valproate exposure: Liver transplantation may be indicated beyond childhood. Liver Transpl 2014;20:1287-9. [PMID: 25179873 DOI: 10.1002/lt.23988] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
71 Saneto RP. Genetics of Mitochondrial Disease. Adv Genet 2017;98:63-116. [PMID: 28942795 DOI: 10.1016/bs.adgen.2017.06.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
72 Lee WS, Sokol RJ. Mitochondrial hepatopathies: advances in genetics, therapeutic approaches, and outcomes. J Pediatr 2013;163:942-8. [PMID: 23810725 DOI: 10.1016/j.jpeds.2013.05.036] [Cited by in Crossref: 35] [Cited by in F6Publishing: 20] [Article Influence: 3.9] [Reference Citation Analysis]
73 Nogueira C, Carrozzo R, Vilarinho L, Santorelli FM. Infantile-Onset Disorders of Mitochondrial Replication and Protein Synthesis. J Child Neurol 2011;26:866-75. [DOI: 10.1177/0883073811402072] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
74 Vozáriková V, Kunová N, Bauer JA, Frankovský J, Kotrasová V, Procházková K, Džugasová V, Kutejová E, Pevala V, Nosek J, Tomáška Ľ. Mitochondrial HMG-Box Containing Proteins: From Biochemical Properties to the Roles in Human Diseases. Biomolecules 2020;10:E1193. [PMID: 32824374 DOI: 10.3390/biom10081193] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
75 Dimauro S, Garone C. Metabolic disorders of fetal life: glycogenoses and mitochondrial defects of the mitochondrial respiratory chain. Semin Fetal Neonatal Med 2011;16:181-9. [PMID: 21620786 DOI: 10.1016/j.siny.2011.04.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.8] [Reference Citation Analysis]
76 Euro L, Haapanen O, Róg T, Vattulainen I, Suomalainen A, Sharma V. Atomistic Molecular Dynamics Simulations of Mitochondrial DNA Polymerase γ: Novel Mechanisms of Function and Pathogenesis. Biochemistry 2017;56:1227-38. [PMID: 28206745 DOI: 10.1021/acs.biochem.6b00934] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
77 Kwong S, Meyerson C, Zheng W, Kassardjian A, Stanzione N, Zhang K, Wang HL. Acute hepatitis and acute liver failure: Pathologic diagnosis and differential diagnosis. Semin Diagn Pathol 2019;36:404-14. [PMID: 31405537 DOI: 10.1053/j.semdp.2019.07.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
78 Goldstein AC, Bhatia P, Vento JM. Mitochondrial disease in childhood: nuclear encoded. Neurotherapeutics 2013;10:212-26. [PMID: 23516041 DOI: 10.1007/s13311-013-0185-6] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
79 Warren EB, Aicher AE, Fessel JP, Konradi C. Mitochondrial DNA depletion by ethidium bromide decreases neuronal mitochondrial creatine kinase: Implications for striatal energy metabolism. PLoS One 2017;12:e0190456. [PMID: 29287112 DOI: 10.1371/journal.pone.0190456] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
80 Martorano L, Peron M, Laquatra C, Lidron E, Facchinello N, Meneghetti G, Tiso N, Rasola A, Ghezzi D, Argenton F. The zebrafish orthologue of the human hepatocerebral disease gene MPV17 plays pleiotropic roles in mitochondria. Dis Model Mech 2019;12:dmm037226. [PMID: 30833296 DOI: 10.1242/dmm.037226] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 3.7] [Reference Citation Analysis]
81 McInnes J. Mitochondrial-associated metabolic disorders: foundations, pathologies and recent progress. Nutr Metab (Lond) 2013;10:63. [PMID: 24499129 DOI: 10.1186/1743-7075-10-63] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 2.1] [Reference Citation Analysis]
82 Oliveira MT, Pontes CB, Ciesielski GL. Roles of the mitochondrial replisome in mitochondrial DNA deletion formation. Genet Mol Biol 2020;43:e20190069. [PMID: 32141473 DOI: 10.1590/1678-4685-GMB-2019-0069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
83 De la Casa-Fages B, Fernández-Eulate G, Gamez J, Barahona-Hernando R, Morís G, García-Barcina M, Infante J, Zulaica M, Fernández-Pelayo U, Muñoz-Oreja M, Urtasun M, Olaskoaga A, Zelaya V, Jericó I, Saez-Villaverde R, Catalina I, Sola E, Martínez-Sáez E, Pujol A, Ruiz M, Schlüter A, Spinazzola A, Muñoz-Blanco JL, Grandas F, Holt I, Álvarez V, López de Munaín A. Parkinsonism and spastic paraplegia type 7: Expanding the spectrum of mitochondrial Parkinsonism. Mov Disord 2019;34:1547-61. [PMID: 31433872 DOI: 10.1002/mds.27812] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
84 Gonzalez-Hunt CP, Rooney JP, Ryde IT, Anbalagan C, Joglekar R, Meyer JN. PCR-Based Analysis of Mitochondrial DNA Copy Number, Mitochondrial DNA Damage, and Nuclear DNA Damage. Curr Protoc Toxicol 2016;67:20.11.1-20.11.25. [PMID: 26828332 DOI: 10.1002/0471140856.tx2011s67] [Cited by in Crossref: 38] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
85 Habibzadeh P, Silawi M, Dastsooz H, Bahramjahan S, Ezzatzadegan Jahromi S, Ostovan VR, Yavarian M, Mofatteh M, Faghihi MA. Clinical and molecular characterization of a patient with mitochondrial Neurogastrointestinal Encephalomyopathy. BMC Gastroenterol 2020;20:142. [PMID: 32384880 DOI: 10.1186/s12876-020-01280-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
86 Gispert S, Parganlija D, Klinkenberg M, Dröse S, Wittig I, Mittelbronn M, Grzmil P, Koob S, Hamann A, Walter M, Büchel F, Adler T, Hrabé de Angelis M, Busch DH, Zell A, Reichert AS, Brandt U, Osiewacz HD, Jendrach M, Auburger G. Loss of mitochondrial peptidase Clpp leads to infertility, hearing loss plus growth retardation via accumulation of CLPX, mtDNA and inflammatory factors. Hum Mol Genet 2013;22:4871-87. [PMID: 23851121 DOI: 10.1093/hmg/ddt338] [Cited by in Crossref: 107] [Cited by in F6Publishing: 100] [Article Influence: 11.9] [Reference Citation Analysis]
87 di Punzio G, Gilberti M, Baruffini E, Lodi T, Donnini C, Dallabona C. A Yeast-Based Repurposing Approach for the Treatment of Mitochondrial DNA Depletion Syndromes Led to the Identification of Molecules Able to Modulate the dNTP Pool. Int J Mol Sci 2021;22:12223. [PMID: 34830106 DOI: 10.3390/ijms222212223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
88 Besse A, Wu P, Bruni F, Donti T, Graham BH, Craigen WJ, McFarland R, Moretti P, Lalani S, Scott KL, Taylor RW, Bonnen PE. The GABA transaminase, ABAT, is essential for mitochondrial nucleoside metabolism. Cell Metab 2015;21:417-27. [PMID: 25738457 DOI: 10.1016/j.cmet.2015.02.008] [Cited by in Crossref: 74] [Cited by in F6Publishing: 70] [Article Influence: 10.6] [Reference Citation Analysis]
89 Chinopoulos C. Quantification of mitochondrial DNA from peripheral tissues: Limitations in predicting the severity of neurometabolic disorders and proposal of a novel diagnostic test. Mol Aspects Med 2020;71:100834. [PMID: 31740079 DOI: 10.1016/j.mam.2019.11.004] [Reference Citation Analysis]
90 Emperador S, Garrido-Pérez N, Amezcua-Gil J, Gaudó P, Andrés-Sanz JA, Yubero D, Fernández-Marmiesse A, O'Callaghan MM, Ortigoza-Escobar JD, Iriondo M, Ruiz-Pesini E, García-Cazorla A, Gil-Campos M, Artuch R, Montoya J, Bayona-Bafaluy MP. Molecular Characterization of New FBXL4 Mutations in Patients With mtDNA Depletion Syndrome. Front Genet 2019;10:1300. [PMID: 31969900 DOI: 10.3389/fgene.2019.01300] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
91 Bulst S, Holinski-Feder E, Payne B, Abicht A, Krause S, Lochmüller H, Chinnery PF, Walter MC, Horvath R. In vitro supplementation with deoxynucleoside monophosphates rescues mitochondrial DNA depletion. Mol Genet Metab 2012;107:95-103. [PMID: 22608879 DOI: 10.1016/j.ymgme.2012.04.022] [Cited by in Crossref: 20] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
92 El-Hattab AW, Scaglia F. Mitochondrial DNA depletion syndromes: review and updates of genetic basis, manifestations, and therapeutic options. Neurotherapeutics 2013;10:186-98. [PMID: 23385875 DOI: 10.1007/s13311-013-0177-6] [Cited by in Crossref: 163] [Cited by in F6Publishing: 142] [Article Influence: 18.1] [Reference Citation Analysis]
93 Rusecka J, Kaliszewska M, Bartnik E, Tońska K. Nuclear genes involved in mitochondrial diseases caused by instability of mitochondrial DNA. J Appl Genet 2018;59:43-57. [PMID: 29344903 DOI: 10.1007/s13353-017-0424-3] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
94 Bebbere D, Ulbrich SE, Giller K, Zakhartchenko V, Reichenbach HD, Reichenbach M, Verma PJ, Wolf E, Ledda S, Hiendleder S. Mitochondrial DNA Depletion in Granulosa Cell Derived Nuclear Transfer Tissues. Front Cell Dev Biol 2021;9:664099. [PMID: 34124044 DOI: 10.3389/fcell.2021.664099] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
95 Kalko SG, Paco S, Jou C, Rodríguez MA, Meznaric M, Rogac M, Jekovec-Vrhovsek M, Sciacco M, Moggio M, Fagiolari G, De Paepe B, De Meirleir L, Ferrer I, Roig-Quilis M, Munell F, Montoya J, López-Gallardo E, Ruiz-Pesini E, Artuch R, Montero R, Torner F, Nascimento A, Ortez C, Colomer J, Jimenez-Mallebrera C. Transcriptomic profiling of TK2 deficient human skeletal muscle suggests a role for the p53 signalling pathway and identifies growth and differentiation factor-15 as a potential novel biomarker for mitochondrial myopathies. BMC Genomics 2014;15:91. [PMID: 24484525 DOI: 10.1186/1471-2164-15-91] [Cited by in Crossref: 64] [Cited by in F6Publishing: 63] [Article Influence: 8.0] [Reference Citation Analysis]
96 Xin Y, Wang Y, Zhong L, Shi B, Liang H, Han J. Slc25a36 modulates pluripotency of mouse embryonic stem cells by regulating mitochondrial function and glutathione level. Biochem J 2019;476:1585-604. [PMID: 31036718 DOI: 10.1042/BCJ20190057] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
97 Barøy T, Pedurupillay CRJ, Bliksrud YT, Rasmussen M, Holmgren A, Vigeland MD, Hughes T, Brink M, Rodenburg R, Nedregaard B, Strømme P, Frengen E, Misceo D. A novel mutation in FBXL4 in a Norwegian child with encephalomyopathic mitochondrial DNA depletion syndrome 13. European Journal of Medical Genetics 2016;59:342-6. [DOI: 10.1016/j.ejmg.2016.05.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
98 De Paepe B, Van Coster R. A Critical Assessment of the Therapeutic Potential of Resveratrol Supplements for Treating Mitochondrial Disorders. Nutrients 2017;9:E1017. [PMID: 28906460 DOI: 10.3390/nu9091017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
99 Paredes JA, Zhou X, Höglund S, Karlsson A. Gene expression deregulation in postnatal skeletal muscle of TK2 deficient mice reveals a lower pool of proliferating myogenic progenitor cells. PLoS One 2013;8:e53698. [PMID: 23341978 DOI: 10.1371/journal.pone.0053698] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
100 Campbell CT, Kolesar JE, Kaufman BA. Mitochondrial transcription factor A regulates mitochondrial transcription initiation, DNA packaging, and genome copy number. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 2012;1819:921-9. [DOI: 10.1016/j.bbagrm.2012.03.002] [Cited by in Crossref: 208] [Cited by in F6Publishing: 208] [Article Influence: 20.8] [Reference Citation Analysis]
101 Krishnan S, Zhou X, Paredes JA, Kuiper RV, Curbo S, Karlsson A. Transgene expression of Drosophila melanogaster nucleoside kinase reverses mitochondrial thymidine kinase 2 deficiency. J Biol Chem 2013;288:5072-9. [PMID: 23288848 DOI: 10.1074/jbc.M112.437152] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
102 Thomas M, Salpietro V, Canham N, Ruggieri M, Phadke R, Kinali M. Mitochondria DNA depletion syndrome in a infant with multiple congenital malformations, severe myopathy, and prolonged postoperative paralysis. J Child Neurol 2015;30:654-8. [PMID: 24789116 DOI: 10.1177/0883073814532546] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
103 Coyne LP, Chen XJ. Consequences of inner mitochondrial membrane protein misfolding. Mitochondrion 2019;49:46-55. [PMID: 31195097 DOI: 10.1016/j.mito.2019.06.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
104 Montero R, Grazina M, López-gallardo E, Montoya J, Briones P, Navarro-sastre A, Land JM, Hargreaves IP, Artuch R, del Mar O'callaghan M, Jou C, Jimenez C, Buján N, Pineda M, García-cazorla A, Nascimento A, Perez-dueñas B, Ruiz-pesini E, Fratter C, Salviati L, Simões M, Mendes C, Santos MJ, Diogo L, Garcia P, Navas P. Coenzyme Q10 deficiency in mitochondrial DNA depletion syndromes. Mitochondrion 2013;13:337-41. [DOI: 10.1016/j.mito.2013.04.001] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
105 González-Vioque E, Torres-Torronteras J, Andreu AL, Martí R. Limited dCTP availability accounts for mitochondrial DNA depletion in mitochondrial neurogastrointestinal encephalomyopathy (MNGIE). PLoS Genet 2011;7:e1002035. [PMID: 21483760 DOI: 10.1371/journal.pgen.1002035] [Cited by in Crossref: 61] [Cited by in F6Publishing: 57] [Article Influence: 5.5] [Reference Citation Analysis]
106 Farnum GA, Nurminen A, Kaguni LS. Mapping 136 pathogenic mutations into functional modules in human DNA polymerase γ establishes predictive genotype-phenotype correlations for the complete spectrum of POLG syndromes. Biochim Biophys Acta 2014;1837:1113-21. [PMID: 24508722 DOI: 10.1016/j.bbabio.2014.01.021] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 3.4] [Reference Citation Analysis]
107 Varma H, Faust PL, Iglesias AD, Lagana SM, Wou K, Hirano M, DiMauro S, Mansukani MM, Hoff KE, Nagy PL, Copeland WC, Naini AB. Whole exome sequencing identifies a homozygous POLG2 missense variant in an infant with fulminant hepatic failure and mitochondrial DNA depletion. Eur J Med Genet 2016;59:540-5. [PMID: 27592148 DOI: 10.1016/j.ejmg.2016.08.012] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 2.8] [Reference Citation Analysis]
108 Kurt YG, Akgul EO, Caycı T. MtDNA depletions are also one of major cause of mitochondrial disease. Mitochondrial DNA 2014;25:303. [PMID: 23808921 DOI: 10.3109/19401736.2013.800509] [Reference Citation Analysis]
109 Huber-ruano I, Errasti-murugarren E, Godoy V, Vera Á, Andreu AL, Garcia-arumi E, Martí R, Pastor-anglada M. Functional outcome of a novel SLC29A3 mutation identified in a patient with H syndrome. Biochemical and Biophysical Research Communications 2012;428:532-7. [DOI: 10.1016/j.bbrc.2012.09.143] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
110 Cámara Y, González-vioque E, Scarpelli M, Torres-torronteras J, Martí R. Feeding the deoxyribonucleoside salvage pathway to rescue mitochondrial DNA. Drug Discovery Today 2013;18:950-7. [DOI: 10.1016/j.drudis.2013.06.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
111 Li S, Huang Y. Ferroptosis: an iron-dependent cell death form linking metabolism, diseases, immune cell and targeted therapy. Clin Transl Oncol 2021. [PMID: 34160772 DOI: 10.1007/s12094-021-02669-8] [Reference Citation Analysis]
112 Saneto RP. Mitochondrial diseases: expanding the diagnosis in the era of genetic testing. J Transl Genet Genom 2020;4:384-428. [PMID: 33426505 DOI: 10.20517/jtgg.2020.40] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
113 Ridge PG, Maxwell TJ, Foutz SJ, Bailey MH, Corcoran CD, Tschanz JT, Norton MC, Munger RG, O'Brien E, Kerber RA, Cawthon RM, Kauwe JS. Mitochondrial genomic variation associated with higher mitochondrial copy number: the Cache County Study on Memory Health and Aging. BMC Bioinformatics 2014;15 Suppl 7:S6. [PMID: 25077862 DOI: 10.1186/1471-2105-15-S7-S6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
114 Medeiros TC, Thomas RL, Ghillebert R, Graef M. Autophagy balances mtDNA synthesis and degradation by DNA polymerase POLG during starvation. J Cell Biol 2018;217:1601-11. [PMID: 29519802 DOI: 10.1083/jcb.201801168] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 6.5] [Reference Citation Analysis]
115 Ceccatelli Berti C, di Punzio G, Dallabona C, Baruffini E, Goffrini P, Lodi T, Donnini C. The Power of Yeast in Modelling Human Nuclear Mutations Associated with Mitochondrial Diseases. Genes (Basel) 2021;12:300. [PMID: 33672627 DOI: 10.3390/genes12020300] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
116 Ignatenko O, Nikkanen J, Kononov A, Zamboni N, Ince-Dunn G, Suomalainen A. Mitochondrial spongiotic brain disease: astrocytic stress and harmful rapamycin and ketosis effect. Life Sci Alliance 2020;3:e202000797. [PMID: 32737078 DOI: 10.26508/lsa.202000797] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
117 Kiliç HB, Bulduk BK, Kocaefe YÇ. A single-tube multiplex qPCR assay for mitochondrial DNA (mtDNA) copy number assessment. Turkish Journal of Biochemistry 2019;44:769-77. [DOI: 10.1515/tjb-2018-0372] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
118 Jackson AP, Laskey RA, Coleman N. Replication proteins and human disease. Cold Spring Harb Perspect Biol 2014;6:a013060. [PMID: 23881941 DOI: 10.1101/cshperspect.a013060] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.3] [Reference Citation Analysis]
119 Stiles AR, Simon MT, Stover A, Eftekharian S, Khanlou N, Wang HL, Magaki S, Lee H, Partynski K, Dorrani N, Chang R, Martinez-Agosto JA, Abdenur JE. Mutations in TFAM, encoding mitochondrial transcription factor A, cause neonatal liver failure associated with mtDNA depletion. Mol Genet Metab 2016;119:91-9. [PMID: 27448789 DOI: 10.1016/j.ymgme.2016.07.001] [Cited by in F6Publishing: 53] [Reference Citation Analysis]
120 Xia CY, Liu Y, Yang HR, Yang HY, Liu JX, Ma YN, Qi Y. Reference Intervals of Mitochondrial DNA Copy Number in Peripheral Blood for Chinese Minors and Adults. Chin Med J (Engl) 2017;130:2435-40. [PMID: 29052564 DOI: 10.4103/0366-6999.216395] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
121 Hershberger KA, Rooney JP, Turner EA, Donoghue LJ, Bodhicharla R, Maurer LL, Ryde IT, Kim JJ, Joglekar R, Hibshman JD, Smith LL, Bhatt DP, Ilkayeva OR, Hirschey MD, Meyer JN. Early-life mitochondrial DNA damage results in lifelong deficits in energy production mediated by redox signaling in Caenorhabditis elegans. Redox Biol 2021;43:102000. [PMID: 33993056 DOI: 10.1016/j.redox.2021.102000] [Reference Citation Analysis]
122 Bianchi M, Rizza T, Verrigni D, Martinelli D, Tozzi G, Torraco A, Piemonte F, Dionisi-Vici C, Nobili V, Francalanci P, Boldrini R, Callea F, Santorelli FM, Bertini E, Carrozzo R. Novel large-range mitochondrial DNA deletions and fatal multisystemic disorder with prominent hepatopathy. Biochem Biophys Res Commun 2011;415:300-4. [PMID: 22027147 DOI: 10.1016/j.bbrc.2011.10.049] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
123 Donkervoort S, Sabouny R, Yun P, Gauquelin L, Chao KR, Hu Y, Al Khatib I, Töpf A, Mohassel P, Cummings BB, Kaur R, Saade D, Moore SA, Waddell LB, Farrar MA, Goodrich JK, Uapinyoying P, Chan SHS, Javed A, Leach ME, Karachunski P, Dalton J, Medne L, Harper A, Thompson C, Thiffault I, Specht S, Lamont RE, Saunders C, Racher H, Bernier FP, Mowat D, Witting N, Vissing J, Hanson R, Coffman KA, Hainlen M, Parboosingh JS, Carnevale A, Yoon G, Schnur RE, Boycott KM, Mah JK, Straub V, Foley AR, Innes AM, Bönnemann CG, Shutt TE; Care4Rare Canada Consortium. MSTO1 mutations cause mtDNA depletion, manifesting as muscular dystrophy with cerebellar involvement. Acta Neuropathol 2019;138:1013-31. [PMID: 31463572 DOI: 10.1007/s00401-019-02059-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 5.3] [Reference Citation Analysis]
124 Font A, Tort F, Navarro-Sastre A, Cusí V, García-Villoria J, Briones P, Ribes A. Quantitative Analysis of mtDNA Content in Formalin-Fixed Paraffin-Embedded Muscle Tissue. JIMD Rep 2011;1:125-9. [PMID: 23430839 DOI: 10.1007/8904_2011_27] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
125 Ignatenko O, Chilov D, Paetau I, de Miguel E, Jackson CB, Capin G, Paetau A, Terzioglu M, Euro L, Suomalainen A. Loss of mtDNA activates astrocytes and leads to spongiotic encephalopathy. Nat Commun 2018;9:70. [PMID: 29302033 DOI: 10.1038/s41467-017-01859-9] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 5.8] [Reference Citation Analysis]
126 Forslund JME, Pfeiffer A, Stojkovič G, Wanrooij PH, Wanrooij S. The presence of rNTPs decreases the speed of mitochondrial DNA replication. PLoS Genet 2018;14:e1007315. [PMID: 29601571 DOI: 10.1371/journal.pgen.1007315] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 4.8] [Reference Citation Analysis]
127 Rooney JP, Ryde IT, Sanders LH, Howlett EH, Colton MD, Germ KE, Mayer GD, Greenamyre JT, Meyer JN. PCR based determination of mitochondrial DNA copy number in multiple species. Methods Mol Biol 2015;1241:23-38. [PMID: 25308485 DOI: 10.1007/978-1-4939-1875-1_3] [Cited by in Crossref: 171] [Cited by in F6Publishing: 159] [Article Influence: 24.4] [Reference Citation Analysis]
128 Varadhachary AS, Weihl CC, Pestronk A. Mitochondrial pathology in immune and inflammatory myopathies. Current Opinion in Rheumatology 2010;22:651-7. [DOI: 10.1097/bor.0b013e32833f108a] [Cited by in Crossref: 24] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
129 Alila-Fersi O, Tabebi M, Maalej M, Belguith N, Keskes L, Mkaouar-Rebai E, Fakhfakh F. First description of a novel mitochondrial mutation in the MT-TI gene associated with multiple mitochondrial DNA deletion and depletion in family with severe dilated mitochondrial cardiomyopathy. Biochem Biophys Res Commun 2018;497:1049-54. [PMID: 29481798 DOI: 10.1016/j.bbrc.2018.02.173] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
130 Vernon HJ, Bindoff LA. Mitochondrial ataxias. Handb Clin Neurol 2018;155:129-41. [PMID: 29891055 DOI: 10.1016/B978-0-444-64189-2.00009-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 1.8] [Reference Citation Analysis]
131 Euro L, Farnum GA, Palin E, Suomalainen A, Kaguni LS. Clustering of Alpers disease mutations and catalytic defects in biochemical variants reveal new features of molecular mechanism of the human mitochondrial replicase, Pol γ. Nucleic Acids Res 2011;39:9072-84. [PMID: 21824913 DOI: 10.1093/nar/gkr618] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
132 Sharp LJ, Haller RG. Metabolic and mitochondrial myopathies. Neurol Clin 2014;32:777-99, ix. [PMID: 25037090 DOI: 10.1016/j.ncl.2014.05.001] [Cited by in Crossref: 28] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
133 Ahlqvist KJ, Hämäläinen RH, Yatsuga S, Uutela M, Terzioglu M, Götz A, Forsström S, Salven P, Angers-Loustau A, Kopra OH, Tyynismaa H, Larsson NG, Wartiovaara K, Prolla T, Trifunovic A, Suomalainen A. Somatic progenitor cell vulnerability to mitochondrial DNA mutagenesis underlies progeroid phenotypes in Polg mutator mice. Cell Metab 2012;15:100-9. [PMID: 22225879 DOI: 10.1016/j.cmet.2011.11.012] [Cited by in F6Publishing: 159] [Reference Citation Analysis]
134 Xie X, Le L, Fan Y, Lv L, Zhang J. Autophagy is induced through the ROS-TP53-DRAM1 pathway in response to mitochondrial protein synthesis inhibition. Autophagy 2012;8:1071-84. [PMID: 22576012 DOI: 10.4161/auto.20250] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 3.9] [Reference Citation Analysis]